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Introduction 
Diminishing ovarian reserve (DOR) refers to 
the reduction of oocyte quantity, quality and 
reproductive potential (1). As per European Society of 
Human Reproduction and Embryology (ESHRE) & 
Bolognas criteria for DOR at least any of the two of the 
following should be present i.e. Age<38 years, 
abnormal ovarian reserve test, and poor response to 
previous stimulated cycle(2). Nowadays 10-30% of 
female infertility is due to DOR (3). As per Institute for 
social and Economic Change (ISEC) survey 14% of 
Indian women attains menopause between the ages of 
29-34 years (4) Aetiologies are heterogeneous, 
associated with X chromosome abnormalities causing 
ovarian dysgenesis (5). Other factors include 
autoimmune (auto-reactive lymphocytosis, organ 
specific autoantibodies), iatrogenic (chemotherapy, 
ovarian drilling and uterine artery embolization), 
oxidative stress (ROS-induced DNA damage causes 
granulosa cell apoptosis, follicular atresia, chromosomal 
abnormalities) and endocrine disrupting chemicals (e.g. 
Polycyclic aromatic hydrocarbons, tobacco (6). Exact 
mechanism for development of DOR is obscure. It can 
be due to preliminary decrease/ defective maturation/
recruitment of primordial follicles and accelerated 
atresia of follicles. Clinical features include vasomotor 
symptoms such as hot flushes, osteoporotic changes, 
vaginal dryness, dyspareunia, sleep disturbances and 
mood swings etc. The long term consequences are 
infertility, premature ovarian failure, osteoporosis, 
cardiovascular, neurologic diseases and risk of 
premature death (7).  
Table 1: Assessment factors (8)  
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Abstract
Diminishing ovarian reserve (DOR) is a condition in which the ovary loses reproductive potential, 
compromising fertility. Nowadays 10-30% of female infertility is due to DOR and considered as “expected poor 
responder” for In vitro fertilisation (IVF).   Correlation of DOR can be done with Dathukshaya vandya (depletion or 
inadequate formation of dhatus) explained in Harithasamhita. The objective of the study was to evaluate the effect of 
Ayurvedic treatment protocol on Diminishing ovarian reserve. The study protocol includes- ashtachurna for deepana 
(appetiser), pachana (digestives) and kolakulathadi churna for udwarthana (powder massage). Sukumaragrutha used 
for snehapana (oral administration of medicated ghee), utharabasthi (intrauterine administration) and rasayana 
(rejuvenation therapy). Danwantarathaila abhyanga (oleation) and ooshmasweda (sudation) done for 3 days. 
Sukumaraeranda was used for virechana (therapeutic purgation) and also Yogabasthi (medicated enema). The study 
design was pre and post interventional study with a sample size of 15 selected as per inclusion and exclusion criteria, 
conducted at hospital for women and children, Government Ayurveda College, Thiruvananthapuram. Assessment was 
based on Bologna criteria for DOR. The statistical techniques employed are Wilcoxon’s signed rank test and Paired t 
test. Results showed statistically significant effect on improving Antral follicle count (AFC) (p- 0.01), Estradiol (p- 
0.005), conception (p- 0.014), on regulating amount of bleeding (p- 0.003), menstrual interval correction (p-0.001) 
and dyspareunia (p-0.005). But insignificant effect on improving Anti Mullerian Hormone (AMH) (p- 0.469) and 
regularising LH/FSH ratio (p-0.104) was found.
Assessment factors Levels (DOR)
Basal Antimullerian 
Hormone (AMH)
Below 1.5 ng/dl
B a s a l F o l l i c l e 
stimulating hormone 
(FSH)
10 - 15 IU/ L
Basal Estradiol 60 - 80 pg/ ml
Basal Inhibin B Less than 400 pg/ ml
Ultra sonography • Antral follicular count 
(AFC< 10 both ovaries)
• Ovarian volume, Ovarian 
artery blood flow
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In conventional medicine system the treatment 
options are limited. DOR is considered as “expected 
poor responder” for In vitro fertilisation (9). Adjuvant 
therapy with LH, DHEA and growth hormones shows 
some benefit in oocyte yield but long term treatment 
may leads to conditions like breast CA, ovarian CA and 
fibroid uterus etc (10).  
Anapathyatha/ Vandhyaha is one among 
vaataja yonivyapath and mentioned as symptom, sign 
and complication of diseases. It means failure to 
achieve a child rather than pregnancy as garbha strava 
(repeated abortions) and mrutvatsa (repeated still births) 
are also included in types (11). Improper dietetics and 
mode of life, abnormalities in the sukra (spermatozoa) 
and asrug (oocyte), diseases of reproductive tract, 
akalayoga (sexual intercourse during non-ovulatory 
phase) and balakshaya (reduction of reproductive 
potential) all are included in the causative factors (12). 
As per Ayurveda, DOR can be most appropriately 
correlated with Dathukshaya vandya, explained in 
Haritha samhita (13). It is due to depletion or 
inadequate formaton of dhatus which leads to reduction 
in fertility potential and ultimately anapathyatha. 
Vandhya chikithsa in Ayurveda comprises a 
multifactorial approach rasayana chikitsa followed by 
shodhana is found to have promising results in 
management of DOR.  
Objective  
To evaluate the effect of Ayurvedic treatment 
protocol on Diminishing Ovarian Reserve. 
Methodology 
Single group, pre and post interventional study 
with sample size of 15 was conducted in the OPD and 
IPD of Govt. Ayurveda college Hospital for women and 
children, Thiruvananthapuram. Inclusion criteria: 
Females in the age group 20-35 years, diagnosed as per 
Bologna criteria. 
Exclusion criteria: Peri- menopausal women, 
systemic illness excluding diabetes mellitus and thyroid 
dysfunction, history of chemotherapy, ovarian drilling 
and auto immune disease. 
Sampling technique: Consecutive selection of 
subjects satisfying inclusion and exclusion criteria  
Primary outcome variables: Basal values of 
AMH, LH/FSH ratio, AFC, and Estradiol. 
Secondary variables: Conception, Amount of 
menstrual bleeding, Menstrual interval dyspareunia 
The statistical techniques: Descriptive statistics, 
Wilcoxon’s signed rank test and Paired t test. 
Table 2: Description of study protocol 
Dynamic test • C l o m i p h e n e c i t r a t e 
chal lenge tes t (CCT), 
Exogenous FSH ovarian 
r e s p o n s e ( E F T O RT ) , 
Gonado t rop in agon i s t 
stimulation test (GAST)
Day Treatment Protocol Medicine
1st-5th Deepana- Pachana
(digestives & appetisers)
Ashtachurna (14)
Dose- 15 gm BD orally
1st-5th Udwarthanam (Powder massage) Kolakulathadi churna (15)
6th-12th Snehapanam 
(Internal administration of medicated 
ghee)
Sukumara grutham (16). Progressively increasing dose 25 
ml to 175 ml
13th-15th Abhyanga and ooshma sweda.
(Oleation & sudaton for 30 minutes )
Dhanwantharam thailam (17).
Dose- Quantity sufficient.
16th Mruduvirechanam. (Therapeutic 
purgation)
Sukumara erandam.
Dose- 20 ml on empty stomach
17th Rest
YOGA BASTHI (Therapeutic enema)
18th Sneha basthi.  (Enema with medicated 
oil)
Dhanwanthara thailam. Dose – 60 ml
19th Sneha basthi Dhanwantharam thailam, -60ml
20th Kashaya basthi.
(Medicated decoction enema)
Sapthasaram kashayam (18), -480 ml     dhanwantharam 
thailam- 120 ml, sathapushpa kalkam 30 gm, 
Saindavam10gm and madhu 120 ml.
21st Sneha basthi Dhanwantharam thailam. 60 ml
22nd Kashaya basthi Sapthasaram kashayam 480 ml, Dhanwantharam thailam 
120 ml.
Sathapushpa kalkam 30 gm, Saindavam 10gm, Madhu -120 
ml
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The study was commenced after the 4th day of menstrual cycle and sodhana suspended during bleeding phase. 
  
Result 
Analysis showed among the study population 80% were vata-paithika prakruthi (body constitution) and 20 % 
vata-kapha prakruthi. Regarding psychological statuses 46.67 % anxious and 26.67% were depressed.  Majority of 
patient had relevant family history of premature menopause (33.33%). In the population (80%) were passive smokers. 
Primary infertility was reason for encounter among all the subjects. All the subjects had history of negative results for 
stimulation strategy. Detailed clinical picture are shown in the diagram 1, 2.  
Diagram: 1 Data regarding treatment history                Diagram: 2 Data regarding clinical picture
 
Table 3: Data related to effectiveness of treatment on AMH &AFC 
Two patients conceived during treatment and 4 patients conceived after treatment. A patient who was 
suggested IVF with donor oocyte (AMH level 1.36 pmol i.e. very low fertility rate) conceived after treatment. Data on 
pre-test and post-test were collected for parameters for rest of the subjects (n=13). Data was assessed with paired t-test 
and Wilcoxon’s signed rank test. 
23rd Sneha basthi Dhanwantharam thailam. -60 ml
24th Kashaya basthi Sapthasara kashayam-480 ml Dhanwantharam thailam- 120 
ml
Sathapushpa kalkam, - 30 gm
Saindavam10 gm and Madhu-120ml
25th Sneha basthi Dhanwantharam thailam.60 ml
26th-28th Uthara basthi. (Intrauterine instillation of 
medication)
Sukumaram grutham- 30 ml
60days Rasayana (Rejuvenation therapy) Sukumara grutham
No AMH  BT (pmol/L)
AMH  
AT (pmol/L)
AFC 
BT
AFC  
AT( 3 months)
AFC 
AF (6 months)
1 3.99 4 5 8 6
2 8.72 8.1 5 10 9
3 3.57 4.29 2 10 Conceived
4 11.74 7.46 6 12 7
5 10.26 20.2 6 8 Conceived
6 15 34.28 5 7 6
7 7.46 Conceived 2 Conceived Conceived
8 1.36 Conceived 4 Conceived Conceived
9 8.31 6.9 2 14 10
10 7.31 4.3 6 16 8
11 2.71 3.5 3 15 12
12 12.27 12.95 4 4 4
13 12.74 9.006 6 11 12
14 12.12 11.9 3 11 10
15 5.53 4.2 5 8 6
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Diagram no.3: Data related to AFC    Diagram no.4: Data related to AMH 
 
BT – Before treatment, AT – After treatment, AF – After follow up 
Diagram no.5: Data related to LH/FSH   Diagram no.6: Data related to Esrtadiol
 
Diagram no.7: Data related to Conception   Diagram no.8: Data related to bleeding 
 
Diagram no.9: Data related to menstrual interval     Diagram no.10: Data related to Dyspareunia 
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Table 4: Paired t-test results
  
Table 5: Wilcoxon’s signed rank test results 
Results showed statistically significant values 
obtained on conception (p-0.014, six patients conceived 
among 15 subjects), regulating amount of bleeding (p- 
0.003), menstrual interval correction (p-0.001), 
minimising dyspareunia (p-0.005), and improving AFC 
(p-value <0.01). After treatment no considerable change 
in ratio LH/FSH ratio (p-value 0.104) was found. 
Before treatment all the patients had normal level of 
mean ovarian volume (>15 cc) Majority were under the 
group7-9 cc and after treatment no difference was 
observed. As the paired t test showed a p-value 0.005, it 
can be concluded that there is statistically significant 
increase of S. Estradiol before treatment and after 
treatment. After treatment considerable increase in 
value AMH was not found. As the paired t test showed a 
p-value 0.469 (i.e., p >0.05), it can be concluded that 
there is statistically insignificant difference between 
AMH before treatment and after treatment (details are 
given in table 4,5).  
Discussion 
From the broad references described in the 
classics the condition like arthava kshaya (19) due to 
apakwa rasadhathu formation as a consequence of 
vishamagni (20) can be considered as reduction in 
reproductive potential due to oxidative stress. 
Symptoms like daaha, santhaapa (hot flushes) rajo 
athipravruthi (shortening of menstrual cycle) are seen 
in early stages of DOR. When untreated and apathya 
sevana (unwholesome habits) is continued leads to 
vaata vrudhi, pitha-kapha kashaya causing rasadi 
d h a t h u k s h a y a i . e . ro o p a a v a s t h a ( d i s ea s e 
manifestation). Vandhyathwa (infertility) due to beeja 
dhushi as seen in shanda, vartha (21) etc. can be 
correlated with premature ovarian failure in X –linked 
chromosomal abnormities. In ovarian surgery 
arthavavaha srotho vighatha (22) can be seen leading to 
arthava nasha (destruction of follicular reserve), 
vandhyathwam and mai thuna asahishnutha 
(dyspareunia) gradually leads to uthorathara 
dhathukshaya (impaired formation of further dhatus) 
where upadrava lakshanaas (complications) like akala 
jara and bala kshaya (e.g. symptoms of early aging.).  
As per Ayurveda vandhyathwa is managed with 
sodhanachikithsa (body purification) and utharavasthi 
so as to get a healthy progeny devoid of beeja dhushti 
(abnormalities of germ cells). Ashta churna is used for 
deepana is kaphavatahara in action. As per Ashtanga 
hrudaya dwividha upakramaneeya adhyaya, rookshana 
should be done prior to snehana chikithsa. (23) Thus for 
rookshana udwarthana is carried out along with 
deepana pachana.  Kolakulathadi churna is 
vatakaphahara in nature. It removes the samaavastha 
and detaches the vitiated dhoshas adhered to srothas. 
Snehana (abhyanthara and bahyasneha) done after 
deepana- pachana. Saptha dhathus are formed from the 
essence of sneha thus proper snehana does jaataragni 
vrudhi (enhances digestive power), koshta visudhi 
(Purifies channels), formation of prathyagra dhathu 
(enhances quality of dhatus), bala (immunity) and 
varna (complexion) also increases life span. Sukumara 
ghritha is used for snehapana, as per indication it is 
pushtidham (improves vitality) also enhances kanthi 
lavanya (complexion), yonishoolahara (reduces painful 
conditions of reproductive tract) and also for men who 
are debilitated with excess sexual intercourse (Nrinaam 
sthreevrinttha barthrunam alakshmi kali nashanam). 
For abhyanga dhanwantharam thailam which is 
tridhoshahara is selected. According to indication it can 
be used in diseases of vata and diseases of female 
reproductive tract (sarvavata vikarajith, kshata 
ksheeneshu poojitham yoniroga kshayapaham). 
Sodhana (vamana, virechana) done after 
purvakarma expels the vitiated dhoshas from koshta. As 
per kasyapa virechana is the main treatment for 
improving beeja karmukatha (increased fertility 
potential of germ cells) (24). It pacifies the vitiated 
kapha and vatadosha and removes vitiated excessive 
Pitta and thus does raktashodhana (blood purification). 
In the present study mrudhu virechana with sukumara 
eranda (dose 20 ml) was opted as it is a dhatuksheena 
avastha (debilitated condition). As it was mudu 
shodhana one day samsarjana karma (regimen after 
sodhana) was done. Vasthi karma is indicated in 
alparaja and anarthava (conditions associated with 
male and female infertility) especially yapanna vasthi is 
indicated in infertility.(25) Here madhuthailika vasthi is 
chosen is having bhrimhana in nature and the drugs are 
dhanwnatharam thailam as snehadravya, sapthasaram 
kashayam which is kapha vatahara in nature and 
indicated in diseases of yoni (reproductive organs). 
Utharavasti should be administered after sodhana. It 
facilitates direct drug administration into uterus and 
accelerates formation of avyapanna garbhava samagri 
(factors essential conception). As per Charaka substance 
which maintains health by producing the best quality of 
rasa, rakta dhatu etc dhatus are called as rasayana. It is 
vayasthapana, ayushkara, medhakara and urjaskara 
(delays aging process, improves memory power and 
vitality). (26) Thus the medicines included in treatment 
protocol will enhance production of avyapanna garbha 
sambhava samagri and hence the preservation of 
fertility status can be restored. 
Variable Test Z P
Conception AF-BT -2.249 0.0414
Amount of 
bleeding
AT-BT -3 0.003
Menustral 
interval
AT-BT -3.225 0.001
Dyspareunia AT-BT -2.828 0.005
Variable Test Z P
Conception AF-BT -2.249 0.0414
Amount of 
bleeding
AT-BT -3 0.003
Menustral 
Interval
AT-BT -3.225 0.001
Dyspareunia AT-BT -2.828 0.005
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Role of vata in the manifestation of disease was 
substantiated by prakruthi assessment i.e vata-paithika, 
vata-kapha prakruthi of subjects. Strong association of 
passive smoking was found. Tobacco is an endocrine 
disrupting chemicals (EDCs) causing alteration of 
ovarian function. EDCs can be correlated with 
dhushivisha (substances in small doses are 
asymptomatic but cumulative effect are hazardous). 
When accumulated over rasadi dhathus causes 
pradhoshaja rogas (diseases due vitiation of dhathu) 
like vandyathwa (27). Primary infertility, shortening of 
menstrual cycle, scanty menstruation, hot flushes and 
dyspareunia are seen in all cases. The study was 
significant at 1% level on conception (46.15%), 
normalizing menstrual interval, increasing amount of 
bleeding, AFC, and dyspareunia though it was not 
effective in increasing in AMH, and regularising FSH/
LH ratio. All the subjects had treatment history 
unresponsive to stimulation strategy. Conception was 
occurred in a patient suggested IVF with donor oocyte 
having AMH level 0.01 (very low fertility rate), AFC= 0 
(value BT) got conceived and also in patients who had 
AMH level below satisfactory level. This indicates 
AMH is not a determining factor and there are other 
unknown factors which favors fertility potential of 
oocyte. Increasing basal values of antral follicles, 
esteradiol indicates appropriate oogenesis. Adopted 
protocol improves the quality of ovum thus restoration 
of fertility potential, along with reduction in the 
magnitude of associated complaints. Cost effectiveness, 
enhanced safety and efficacy will benefit for the society 
and will project Ayurveda into the main stream 
treatment. 
Conclusion 
Study shows significant effect on markers of 
ovarian reserve such as antral follicle count and 
estradiol and also in the clinical parameters such as 
conception, regulating menstrual bleeding pattern, 
interval and dyspareunia. But significant effect on Anti 
Mullerian Hormone and regularising LH/FSH ratio was 
not found. For precise data researches on larger samples 
have to be conducted. Pregnancy is the conclusive 
evidence for restoration fertility potential. Even though 
conspicuous change in the markers of ovarian reserve 
was established it’s evident that the study is effective in 
managing diminishing ovarian reserve.  
References  
1. Artini PG, Ruggiero M, Uccelli A, Obino ME, Cela 
V (2013) Fertility Management of Patients with 
Reduced Ovarian Reserve. Reprod Sys Sexual 
Disorders S5:006. doi:10.4172/2161-038X.S5-006 
2. Testing and interpreting measures of ovarian 
reserve: Fertil Steril 2015; 103: e9-e17 
3. J Clin Invest. 2007; 117(12):3971-3978. https://
doi.org/10.1172/JCI28493. 
4. www.isec.ac.in 
5. Rasool S, Shah D. Fertility with early reduction of 
ovarian reserve: the last straw that breaks the 
Camel’s back. Fertility Research and Practice. 
2017;3:15. doi:10.1186/s40738-017-0041-1.  
6. Mandeep kaur,Mala Arora. Diminishing ovarian 
reserve, causes, assessment and management. 
IJIFM.2013-May-25, volume (No. 2) 45-54 page 
no. 
7. Pratap Kumar, Narendra Malhotra. Jeffcoate’s 
Principles of Gynaecology. 7th ed. New Delhi: 
Jaypee Brother Medical Publishers (P) Ltd; 2008. 
8. Schorge, Schaffer, Halvorson, Hoffman, Bradshaw, 
Cunningham. Williams Gynaecology, China 
Translation and Printing Ltd; 2008. 371, 456, 457, 
369, 391, 378. 
9. Greene AD, Patounakis G, Segars JH. Genetic 
associations with diminished ovarian reserve: a 
systematic review of the literature. J Assist Reprod 
Genet. 2014;31:935–46 
10. https://www.centerforhumanreprod.com.  
11. Pandith.Hariprasad tripadi. Haritha samhitha. 4th ed. 
Varanasi: Chowkhamba Krishnadas Academy: 2015 
445-448 page. 
12. Premvati Tewari. Ayurvediya Prasutitantra Evam 
S t r e e r o g a P a r t 2 . 2 n d e d . Va r a n a s i : 
ChaukhambaOrientalia; 1999. Page no 356 
13. Pandith.Hariprasad tripadi. Haritha samhitha. 4th ed. 
Varanasi: Chowkhamba Krishnadas Academy: 2015 
445-448 page. 
14. Aravattzhikathu K V Krishnanvaidyan, Aanekaleelil 
S Gopalapilla. Sahasra Yogam Sujanapriya 
Commentary. 27th ed. Aalapuzha: Vidhyarambham 
publishers; 2007, Page no 81 
15. Aravattzhikathu K V Krishnanvaidyan, Aanekaleelil 
S Gopalapilla. Sahasra Yogam Sujanapriya 
Commentary. 27th ed. Aalapuzha: Vidhyarambham 
publishers; 2007, Page no 154 
16. Aravattzhikathu K V Krishnanvaidyan, Aanekaleelil 
S Gopalapilla. Sahasrayogam Sujanapriya 
Commentary. 27th ed. Aalapuzha: Vidhyarambham 
publishers; 2007, Page no 454 
17. Aravattzhikathu K V Krishnanvaidyan, Aanekaleelil 
S Gopalapilla. Sahasra Yogam Sujanapriya 
Commentary. 27th ed. Aalapuzha: Vidhyarambham 
publishers; 2007, Page no 235 
18. Aravattzhikathu K V Krishnanvaidyan, Aanekaleelil 
S Gopalapilla. Sahasra Yogam Sujanapriya 
commentary. 27th ed. Aalapuzha: Vidhyarambham 
publishers; 2007, Page no 332 
19. Sreekantha Murthy KR. Susrutha Samhitha. Vol.3. 
Revised ed. Varanasi:    Chowkhamba Orientalia: 
2015. 567 page no.268 
20. Yadavji Trikamji Acharya. CharakaSamhitha by 
Agnivesha, Revised by Caraka and Dridhabala with 
“Ayurveda deepika”commentary of Cakrapanidatta. 
Varanasi: Chaukhamba Krishnadas Academy; 
Samskarana 2006. Page no 855 
21. Sreekumar .T. MD(Ay) PhD. Vagbhata’s Astanga 
Hridaya Sutrasthana-1,English Translation and 
Commentary. 1st ed. Thrissur: Publication 
Department Harisree Hospital; 2011, page no564 
22. Chunekar K.C, G.S.Pandey. Bhavaprakasa 
nighantu. 10thed. Varanasi: Chaukhamba Bharati 
Academy; 1995 page 654 
233

International Journal of Ayurvedic Medicine, Vol 11 (2), 228-234
Published online in http://ijam.co.in 
  
ISSN No: 0976-5921
23. Sreekumar.T MD(Ay) PhD. Vagbhata’s Astanga 
Hridaya Sutrasthana-1,English Translation and 
Commentary. 1st ed. Thrissur: Publication 
Department Harisree Hospital; 2011, page no   
24. Usha.V.N.K A Text Book of Gynaecology-
StreerogaVijnan. 1st ed. Delhi: Chaukhamba 
Sanskrit Pratishthan; 2010 Volume 2, Page no245 
25. Yadavji Trikamji Acharya. CharakaSamhitha by 
Agnivesha, Revised by Caraka and Dridhabala with 
“Ayurveda deepika”commentary of Cakrapanidatta. 
Varanasi: Chaukhamba Krishnadas Academy; 
Samskarana 2006.Page no467 
26. 26. Yadavji Trikamji Acharya. CharakaSamhitha by 
Agnivesha, Revised by Caraka and Dridhabala with 
“Ayurveda deepika”commentary of Cakrapanidatta. 
Varanasi: Chaukhamba Krishnadas Academy; 
Samskarana 2006. Page no 675. 
27. Jyotir Mitra, Ashtanga Sangraha: Chaukhamba 
Krishnadas Academy; 2002 Page no 152. 
*****
234
